Post by Visium

Most AI investment in pharma targets drug discovery. 💊 The regulatory submission is often the last step to get attention, yet it remains one of the most labour-intensive, demanding handoffs between a molecule and the market. We looked at what is actually changing: where AI is reducing the time spent on dossier assembly, how it handles the volume and precision that structured submissions require, and why the EMA-FDA push toward aligned standards matters for regulatory teams building these workflows now. The link to the full article is in the comments. 👇 #RegulatoryAffairs #AIinPharma #LifeSciences #Pharma